Subscribe To
Regeneron Completes Acquisition of Decibel Therapeutics, Adding Promising Gene Therapy Programs for Hearing Loss
TARRYTOWN, N.Y., Sept. 25, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has successfully completed its acquisition of Decibel Therapeutics, Inc., strengthening the company’s gene therapy and auditory programs. The acquisition of Decibel builds on prior collaboration between the companies and includes three ongoing gene therapy programs targeting different forms […] The post Regeneron Completes Acquisition of Decibel Therapeutics, Adding Promising...
Read More
Content Topics
Regeneron
Completes
Acquisition
Decibel
Therapeutics
Adding
Therapeutics
Promising
Therapy
Programs
Hearing
Forex
Posted: Sep 25 2023, 12:34
Author Name: forextv
Views: 092052